Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Emergent Biosolutions Inc. buy Rodman & Renshaw

Start price
€9.52
22.08.24 / 50%
Target price
€14.36
22.08.25
Performance (%)
-10.53%
Price
€8.52
23.08.24
Summary
This prediction is currently active. The prediction for Emergent Biosolutions Inc. disappoints with a performance of -10.53%. This prediction currently runs until 22.08.25. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this prediction
Performance without dividends (%)
Name 1w
Emergent Biosolutions Inc. -10.53%
iShares Core DAX® 1.665%
iShares Nasdaq 100 -0.475%
iShares Nikkei 225® 2.620%
iShares S&P 500 -0.091%

Comments by Rodman___Renshaw for this prediction

In the thread Emergent Biosolutions Inc. diskutieren
Prediction Buy
Perf. (%) -10.53%
Target price 14.357
Change
Ends at 22.08.25

Emergent BioSolutions Inc. (NYSE: EBS) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock.
Ratings data for EBS provided by MarketBeat